DR. JAMES THOMAS LINK M. D. PHD NPI 1063775104

NPI Details

DR. James Thomas Link, M. D., PHD is a hematology and oncology internal medicine in Lone Tree, CO with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. James Thomas Link, M. D., PHD NPI is 1063775104. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

10240 PARK MEADOWS DR
LONE TREE, CO
ZIP 80124-425
Phone: (303) 338-4545

The NPI 1063775104 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, daratumumab, 10 mg (HCPCS:J9145)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Reticulated (young) platelet measurement (HCPCS:85055)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Collection of blood sample from implanted device (HCPCS:36591)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Ferritin (blood protein) level (HCPCS:82728)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ct scan of chest with contrast (HCPCS:71260)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Unclassified drugs (HCPCS:J3490)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Urinalysis, manual test (HCPCS:81002)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Red blood count, automated test (HCPCS:85045)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)

The enumeration date for this NPI number is 6/22/2012 and was last updated on 9/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.